Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy.
Oncotarget
; 8(35): 58108-58121, 2017 Aug 29.
Article
en En
| MEDLINE
| ID: mdl-28938541
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Año:
2017
Tipo del documento:
Article